Skip to main content

Peer Review reports

From: How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?

Original Submission
24 Jun 2021 Submitted Original manuscript
24 Sep 2021 Reviewed Reviewer Report
4 Oct 2021 Reviewed Reviewer Report
28 Oct 2021 Author responded Author comments - Ava Kwong
Resubmission - Version 2
28 Oct 2021 Submitted Manuscript version 2
2 Nov 2021 Author responded Author comments - Ava Kwong
Resubmission - Version 3
2 Nov 2021 Submitted Manuscript version 3
10 Nov 2021 Reviewed Reviewer Report
24 Nov 2021 Reviewed Reviewer Report
1 Dec 2021 Author responded Author comments - Ava Kwong
Resubmission - Version 4
1 Dec 2021 Submitted Manuscript version 4
9 Dec 2021 Author responded Author comments - Ava Kwong
Resubmission - Version 5
9 Dec 2021 Submitted Manuscript version 5
22 Dec 2021 Author responded Author comments - Ava Kwong
Resubmission - Version 6
22 Dec 2021 Submitted Manuscript version 6
19 Jan 2022 Reviewed Reviewer Report
10 Feb 2022 Author responded Author comments - Ava Kwong
Resubmission - Version 7
10 Feb 2022 Submitted Manuscript version 7
15 Feb 2022 Author responded Author comments - Ava Kwong
Resubmission - Version 8
15 Feb 2022 Submitted Manuscript version 8
24 Feb 2022 Author responded Author comments - Ava Kwong
Resubmission - Version 9
24 Feb 2022 Submitted Manuscript version 9
1 Mar 2022 Author responded Author comments - Ava Kwong
Resubmission - Version 10
1 Mar 2022 Submitted Manuscript version 10
22 Mar 2022 Author responded Author comments - Ava Kwong
Resubmission - Version 11
22 Mar 2022 Submitted Manuscript version 11
25 Mar 2022 Author responded Author comments - Ava Kwong
Resubmission - Version 12
25 Mar 2022 Submitted Manuscript version 12
Publishing
30 Mar 2022 Editorially accepted
31 May 2022 Article published 10.1186/s12920-022-01270-4

You can find further information about peer review here.

Back to article page